Filing Flows › Biotricity (BTCY) › Q1 FY27
Biotricity (BTCY) Q1 FY27 earnings results (first quarter fiscal 2027)
10-Q filed Aug 19, 2026
Biotricity (BTCY) reported revenue of $4.3M for the first quarter fiscal 2027 (Q1 FY27), +10% from a year earlier and +0.6% from the quarter before. Operating margin was 3.7%, net loss $959K (22.4% of revenue).
Biotricity, Q1 FY27: revenue $4.3M (+10% year over year), operating margin 3.7%, net loss $959K, operating cash flow $507K. The chart follows the revenue to costs, profit and cash.
| Q1 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.3M | +0.6% | +10% |
| Operating profit | $158K | -77% | -44% |
| Net earnings | −$959K | — | — |
| Operating cash flow | $507K | — | — |
What changed
Revenue was $4.3M in Q1 FY27, up 10% year over year and up 1% from the previous quarter. Technology Fees was the largest line at 97% of revenue. Technology Fees added $795K year over year (up 24%), 197% of the total change. Device Sales declined 78%.
Gross margin was 82.6%, up 2.1 points from Q1 FY26. Operating profit was $158K, a 3.7% margin (down 3.6 points year over year). Operating profit fell $124K even though revenue rose $403K versus Q1 FY26, so costs grew faster than sales. Operating expenses grew 19% against revenue growth of 10%. The fastest-growing cost line was SG&A (+26%). The quarter ended with a net loss of $1.0M, wider than the previous quarter's $324K loss. Net interest and other expense of $1.1M was the main reason.
Operating cash flow was $507K. Non-cash charges added back $1K of depreciation and $340K of share-based compensation. Working capital and other items added $1.1M.
Questions
What was Biotricity's revenue in the first quarter fiscal 2027?
Biotricity (BTCY) reported revenue of $4.3M for the first quarter fiscal 2027 (Q1 FY27), +10% from a year earlier and +0.6% from the quarter before.
Was Biotricity profitable in the first quarter fiscal 2027?
Operating profit was $158K (3.7% of revenue) and net loss $959K.
Source: Biotricity 10-Q on SEC EDGAR.